However, the observation that promoting MVB formation can be either oncogenic (via the activation of Hrs and Syntenin) or tumor suppressing (via the activation of Vps4A and HD-PTP) in a molecule-specific and cell-type-specific manner is a major barrier to translational application. Here, PTPN23 is linked to neoplasm.